Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
HIV
Interventions
DRUG

Tripterygium Wilfordii Hook F extract (TwHF extract)

The extract Tripterygium wilfordii Hook F (TwHF), a traditional Chinese medication, has been used as anti-inflammatory therapy to treat autoimmune diseases including rheumatoid arthritis and Crohn's disease.

DRUG

cART

Participants who will be enrolled in this trial would keep their previous combined antiretroviral therapy, such as zidovudine or stavudine plus lamivudine plus nevirapine or efavirenz.

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

LI Taisheng

OTHER

NCT02002286 - Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses | Biotech Hunter | Biotech Hunter